|
|
Blood, 15 May 2006, Vol. 107, No. 10, pp. 3868-3875.
Prepublished online as a Blood First Edition Paper on January 24, 2006; DOI 10.1182/blood-2005-07-2755.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis
Harald Schulze,
Manav Korpal,
Jonathan Hurov,
Sang-We Kim,
Jinghang Zhang,
Lewis C. Cantley,
Thomas Graf, and
Ramesh A. Shivdasani
From the Dana-Farber Cancer Institute, Boston, MA; the Department of Medicine, Harvard Medical School, Boston, MA; the Beth Israel-Deaconess Medical Center, Boston, MA; and the Albert Einstein College of Medicine, Bronx, NY.
To produce blood platelets, megakaryocytes elaborate proplatelets, accompanied by expansion of membrane surface area and dramatic cytoskeletal rearrangements. The invaginated demarcation membrane system (DMS), a hallmark of mature cells, has been proposed as the source of proplatelet membranes. By direct visualization of labeled DMS, we demonstrate that this is indeed the case. Late in megakaryocyte ontogeny, the DMS gets loaded with PI-4,5-P2, a phospholipid that is confined to plasma membranes in other cells. Appearance of PI-4,5-P2 in the DMS occurs in proximity to PI-5-P-4-kinase (PIP4K ), and short hairpin (sh) RNA-mediated loss of PIP4K impairs both DMS development and expansion of megakaryocyte size. Thus, PI-4,5-P2 is a marker and possibly essential component of internal membranes. PI-4,5-P2 is known to promote actin polymerization by activating Rho-like GTPases and Wiskott-Aldrich syndrome (WASp) family proteins. Indeed, PI-4,5-P2 in the megakaryocyte DMS associates with filamentous actin. Expression of a dominant-negative N-WASp fragment or pharmacologic inhibition of actin polymerization causes similar arrests in proplatelet formation, acting at a step beyond expansion of the DMS and cell mass. These observations collectively suggest a signaling pathway wherein PI-4,5-P2 might facilitate DMS development and local assembly of actin fibers in preparation for platelet biogenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Proplatelet formation: unraveling the megakaryocyte swan song
- Andrew D. Leavitt
Blood 2006 107: 3816-3817.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. Strassel, A. Eckly, C. Leon, C. Petitjean, M. Freund, J.-P. Cazenave, C. Gachet, and F. Lanza
Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome
Haematologica,
June 1, 2009;
94(6):
800 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eckly, C. Strassel, M. Freund, J.-P. Cazenave, F. Lanza, C. Gachet, and C. Leon
Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation
Blood,
April 2, 2009;
113(14):
3182 - 3189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Eto, H. Nishikii, T. Ogaeri, S. Suetsugu, A. Kamiya, T. Kobayashi, D. Yamazaki, A. Oda, T. Takenawa, and H. Nakauchi
The WAVE2/Abi1 complex differentially regulates megakaryocyte development and spreading: implications for platelet biogenesis and spreading machinery
Blood,
November 15, 2007;
110(10):
3637 - 3647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Kile, A. D. Panopoulos, R. A. Stirzaker, D. F. Hacking, L. H. Tahtamouni, T. A. Willson, L. A. Mielke, K. J. Henley, J.-G. Zhang, I. P. Wicks, et al.
Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia
Blood,
October 1, 2007;
110(7):
2371 - 2380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Junt, H. Schulze, Z. Chen, S. Massberg, T. Goerge, A. Krueger, D. D. Wagner, T. Graf, J. E. Italiano Jr., R. A. Shivdasani, et al.
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
Science,
September 21, 2007;
317(5845):
1767 - 1770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, O. Naveiras, A. Balduini, A. Mammoto, M. A. Conti, R. S. Adelstein, D. Ingber, G. Q. Daley, and R. A. Shivdasani
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway
Blood,
July 1, 2007;
110(1):
171 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chang, F. Aurade, F. Larbret, Y. Zhang, J.-P. Le Couedic, L. Momeux, J. Larghero, J. Bertoglio, F. Louache, E. Cramer, et al.
Proplatelet formation is regulated by the Rho/ROCK pathway
Blood,
May 15, 2007;
109(10):
4229 - 4236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, M. Hu, and R. A. Shivdasani
Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2
Blood,
February 15, 2007;
109(4):
1451 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|